The activation of the aryl hydrocarbon receptor (AhR) promotes the expression of anti-inflammatory cells and anti-inflammatory factors and inhibits the immune response, and AhR inhibitors have become key therapeutic agents for the treatment of psoriasis [126]. The gene discussed is AHR; the disease is psoriasis.